Duovir N Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Duovir N Tablet is a fixed-dose combination of lamivudine and zidovudine (nucleoside reverse transcriptase inhibitors) with nevirapine (a non-nucleoside reverse transcriptase inhibitor). Its labelling describes it for the treatment of HIV infection in adults, taken with or without food at the same time each day. It is described as controlling the infection and is not for use as prevention or as post-exposure treatment.
Product Information
The following description reflects information associated with lamivudine, nevirapine, and zidovudine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of HIV infection in adults
- Described as stopping the virus from multiplying and helping the immune system work better
- Described as not for use as prevention or as a cure after accidental exposure to HIV or AIDS
Described Dosage & Administration
- Swallowed whole with or without food; tablets should not be crushed, broken, or chewed
- Taken at about the same time each day to support effective treatment
- The prescriber sets the dose and duration; the full course should be completed and not stopped without the doctor’s permission
Described Side Effects
Commonly described side effects include:
- Rash
- Headache
- Abdominal pain
- Muscle pain
These are described as commonly temporary. Any severe, persistent, or unexpected reaction — including a serious skin reaction or signs of liver problems — requires prompt medical attention.
Precautions
- An updated medical history with all medicines taken currently or recently should be shared with the doctor
- Personal belongings should not be shared with others
- The healthcare team’s tests, such as blood counts and kidney and liver function, should be cooperated with
- Any persistent or severe side effect should be reviewed by a clinician
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it combines lamivudine, nevirapine, and zidovudine for the treatment of HIV infection in adults, described as stopping the virus from multiplying. It is described as not for prevention or post-exposure use. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed whole with or without food at about the same time each day, and not crushed, broken, or chewed. The full course should be completed and not stopped without the doctor’s permission.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.